NMN protects vascular endothelial cells from M1 macrophage-derived IL-1β-induced hyperpermeability by inhibiting VE-cadherin degradation - Top-Institutions - MDSpire

NMN protects vascular endothelial cells from M1 macrophage-derived IL-1β-induced hyperpermeability by inhibiting VE-cadherin degradation

  • By

  • Takeshi Katayoshi

  • Takahisa Nakajo

  • Natsuko Kitajima

  • Wakana Naka

  • Yuki Kamei

  • Taiki Fushimi

  • Masakatsu Kageyama

  • Mitsugu Akagawa

  • Kentaro Tsuji

  • May 18, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Lonza
    Lonza

    Basel, Switzerland

    Key Differentiators

    • Cell Biology
    • Pharmacology

  • #2

    Japanese Collection of Research Bioresources Cell Bank
    Japanese Collection of Research Bioresources Cell Bank

    Osaka, Japan

    Key Differentiators

    • Cell Biology
    • Biotechnology

  • #3

    University of Calgary
    University of Calgary

    Calgary, Alberta

    Key Differentiators

    • Cardiology
    • Neuroscience

  • #4

    CONDI2/ERIC-PPCI trial
    CONDI2/ERIC-PPCI trial

    N/A, N/A

    Key Differentiators

    • Cardiology
    • Clinical Trials

  • #5

    National Institute of Neurological Disorders and Stroke
    National Institute of Neurological Disorders and Stroke

    Bethesda, Maryland

    Key Differentiators

    • Neurology
    • Cardiology

Original Source(s)

NMN protects vascular endothelial cells from M1 macrophage-derived IL-1β-induced hyperpermeability by inhibiting VE-cadherin degradation

  • by Takeshi Katayoshi, Takahisa Nakajo, Natsuko Kitajima, Wakana Naka, Yuki Kamei, Taiki Fushimi, Masakatsu Kageyama, Mitsugu Akagawa, Kentaro Tsuji

  • May 18, 2026

Related Content

AHA Updates Heart-Healthy Dietary Guidance

Nine evidence-based features now frame cardiovascular risk reduction across the life course, with sharper language on alcohol, ultraprocessed foods, and plant protein

Low Follow-Up After Behavioral ED Care

Follow-up occurred after fewer than 15% of mental health ED visits and about 11% of substance use–related visits in Washington Medicaid claims.

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.